Compound 7p was shown to induce the growth of GAP-43-positive axons in an animal model of optic nerve injury, suggesting that the neurite outgrowth activity of compound 7p in vitro translates into stimulation of axon regeneration in vivo. Compound 7P powder is a white to off-white powder produced as a tandem compound for the identification of dual-acting thromboxane receptor antagonist inhibitors. Indeed, compound 7p exhibits selectivity for prostaglandin I2 synthase (PTGIS, CYP8A1) over thromboxane synthase (CYP5A1). A nootropic is any substance that helps improve brain function, including memory, concentration, mood, and even intelligence. They can range from certain food groups or items to man-made compounds specifically designed to aid brain function and other benefits. Nootropic compound 7P powder promotes outgrowth of Gap-43 positive axons, thereby stimulating axonal regeneration in vivo. High-quality compound 7p is designed to improve coordination, improve mood and help fight fatigue. It also prevents oxidation of the brain and helps fight brain damage caused by alcohol consumption.Neurons in the adult central nervous system (CNS) fail to regenerate axons after injury, which in part explains poor functional recovery in patients with trauma and neurodegenerative diseases. Compound 7p, which enhances neurite outgrowth in cultured primary neurons derived from the hippocampus, cerebral cortex, and retina, and induces optic nerve regeneration in an animal model of optic nerve injury. It also increases coordination, treats alcohol-related brain damage, and prevents oxidation around the brain. Also helps to improve one's mood and fight fatigue. Additionally compound 7P showed the highest activity against cervical tumors by improving the microstructure in a dose-dependent manner. Further optimization of compound 7p and elucidation of the mechanism by which it triggers axon regeneration in vivo will provide a rationale for future efforts to strengthen therapeutic strategies.
